Abstract

The blood-brain barrier (BBB) contributes to brain homeostasis by protecting the brain from harmful compounds. P-glycoprotein (P-gp) is one of the major efflux transporters at the BBB. In the present study, we assessed whether (1) P-gp function in the brain is constant or fluctuates across the day and (2) if it is affected by sleep deprivation. Four groups of rats were PET scanned with a radiolabeled P-gp substrate [18F]MC225, each at a different moment of the 12-h light-dark cycle to study diurnal variations: early sleep phase (ZT3), late sleep phase (ZT9), early active phase (ZT15), and late active phase (ZT21). In two additional groups, controls were allowed to sleep normally while experimental animals were sleep-deprived for 10h in a slowly rotating drum during the sleep phase. Kinetic modeling with a one-tissue compartment model fit resulted for all brain regions in 1.2-1.8-fold higher distribution volumes (V T ) at ZT15 than at other time points. V T -values at ZT3, ZT9, and ZT21 were not significantly different from each other. Regional tracer distribution volumes in controls and sleep-deprived animals were also not significantly different. Our results indicate that P-gp function in rats displays a daily rhythm with reduced function at the beginning of the active phase. This rhythm is not dependent on sleep since acute sleep deprivation had no effect. Knowing the diurnal variation of P-gp function could be important for the design of PET studies and for choosing the correct administration time for P-gp-dependent drugs.

Highlights

  • P-glycoprotein (P-gp) is expressed on the luminal side of endothelial cells in the blood-brain barrier (BBB) [1, 2]

  • Metabolite-corrected plasma time-activity curves (SUV) at ZT15 were significantly different from those acquired at ZT3 and ZT9 (p = 0.026, and p < 0.001, respectively, Fig. 2a) when area under the curve (AUC) 0–60 min was compared

  • The 1TCM has been identified as the preferred kinetic model for analysis of [18F]MC225 positron emission tomography (PET) data [22]

Read more

Summary

Introduction

P-glycoprotein (P-gp) is expressed on the luminal side of endothelial cells in the blood-brain barrier (BBB) [1, 2]. This transporter protects the brain by pumping a wide variety of substances back into the blood. Little is known about physiological fluctuations in P-gp function across the day in relation to the circadian rhythm. Such fluctuations could be important for selecting the optimal time of the day for application of therapeutic drugs. Many CNS drugs have some affinity for P-gp, e.g., certain anticancer drugs, antidepressants, and HIV-protease inhibitors [8,9,10,11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call